Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) – review
, , and
Dec 17, 2020
About this article
Published Online: Dec 17, 2020
Page range: 199 - 208
Received: Jun 10, 2020
DOI: https://doi.org/10.2478/rjim-2020-0017
Keywords
© 2020 Nicoleta Iftode et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Human herpesvirus 8 (HHV8), also known as Kaposi sarcoma-associated herpesvirus (KSHV), is one of the few pathogens recognized as direct carcinogen, being involved in the pathogenesis of Kaposi sarcoma, primary effusion lymphoma and multicentric Castleman disease. KSHV is a relatively recently discovered virus, with still limited possibilities for diagnosis and treatment. Therefore, ongoing studies are trying to answer the main issues related to the management of KSHV infection and its associated diseases. This review updates the current knowledge of the KSHV infection, discussing aspects related to epidemiology, virological features, clinical manifestations, diagnosis and treatment.